These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2829048

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Involvement of dynorphin and the kappa opioid receptor in feeding.
    Morley JE, Levine AS.
    Peptides; 1983; 4(6):797-800. PubMed ID: 6143298
    [Abstract] [Full Text] [Related]

  • 6. Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
    Bansinath M, Ramabadran K, Turndorf H, Shukla VK.
    Brain Res Bull; 1991 Jul; 27(1):75-9. PubMed ID: 1657321
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
    Shukla VK, Turndorf H, Bansinath M.
    Eur J Pharmacol; 1995 Mar 16; 292(3-4):293-9. PubMed ID: 7796869
    [Abstract] [Full Text] [Related]

  • 10. Highly selective kappa-opioid analgesics. 3. Synthesis and structure-activity relationships of novel N-[2-(1-pyrrolidinyl)-4- or -5-substituted-cyclohexyl]arylacetamide derivatives.
    Halfpenny PR, Horwell DC, Hughes J, Hunter JC, Rees DC.
    J Med Chem; 1990 Jan 16; 33(1):286-91. PubMed ID: 2153208
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of U50,488, a selective kappa agonist, on atypical mouse opiate systems.
    Marrazzi MA, Lawhorn J, Graham V, L'Abbe D, Mullings-Britton J, Stack L, Eccles T.
    Brain Res Bull; 1990 Jul 16; 25(1):199-201. PubMed ID: 2169965
    [Abstract] [Full Text] [Related]

  • 14. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated.
    Bals-Kubik R, Herz A, Shippenberg TS.
    Psychopharmacology (Berl); 1989 Jul 16; 98(2):203-6. PubMed ID: 2569217
    [Abstract] [Full Text] [Related]

  • 15. Differential response to kappa-opioidergic agents in dietary fat selection between Osborne-Mendel and S5B/P1 rats.
    Ookuma K, Barton C, York DA, Bray GA.
    Peptides; 1998 Jul 16; 19(1):141-7. PubMed ID: 9437746
    [Abstract] [Full Text] [Related]

  • 16. Effects of kappa-opioid receptor agonists and morphine on food intake and urinary output in food-deprived and nondeprived rats.
    Ramarao P, Bhargava HN.
    Pharmacol Biochem Behav; 1989 Jun 16; 33(2):375-80. PubMed ID: 2554341
    [Abstract] [Full Text] [Related]

  • 17. Behavioural effects of selective mu-, kappa-, and delta-opioid agonists in neonatal rats.
    Jackson HC, Kitchen I.
    Psychopharmacology (Berl); 1989 Jun 16; 97(3):404-9. PubMed ID: 2541460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
    Horan PJ, de Costa BR, Rice K, Haaseth RC, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 1993 Aug 16; 266(2):926-33. PubMed ID: 8394923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.